2Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective eyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs[J]. BMJ, 2002,325(7365):607-608.
3Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial[J]. JAMA, 1999,282(20) : 1921-1928.
4Laporte JR, Ibanez L, Vidal X, etal. Upper gastroin testinal bleeding associated with the use of NSAIDs newer versus older agents[J1. Drug Saf, 2004,27 (6) 411-420.
5Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations [J]. Gut, 2006, 55 (12):1731-1738.
6Hallas J, Lauritsen J, Villadsen HD, et al. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates[J]. Scand J Gastroenterol, 1995, 30 (5) : 438-444.
二级参考文献7
1Shamoon M, Mochberg MC. Treawaent of osteoarthritis with acetaminophen: efficacy, safety, and comparison with nonsteroidal antiinflammatory drugs. Curr Rheumatol Rep ,2000,2(6) :454
2Laine L. Gasuointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage Suppl,2003,25(2) :S32
3Marie R, Griffin MD. Epidemiology of nonsteroidal anti-inflammatory drug associated gastrointestinal injury. Am J Med, 1998, 104(3A): 23S
4James F, Fries MD, Catherine A, et al. Nonsteroidal anti-inflammatory drug associated gastropathy: incidence and risk factor models.Am J Med, 1991,91:213
5Altrnan R, Rouvier J, Gurfinkel E, et al. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treatment with oral anticoagulant. Circ, 1996,94 (9): 2113
6Food and Drug Administration, HHS. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates:Reye' s syndrome warning. Final rule. Fed Regist, 2003,68(74): 18861
7Wallace JL. Selective COX- 2 inhibitors:is the water becoming muddy?Trends in Pharmacol , 1999,20(1) :4
